STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +21 more
- Informational Intervention
- Survey Administration
- New Brunswick, New Jersey
- +1 more
2022-04-06
Apr 6, 2022H
Completed
- Malignant Melanoma
- patient with melanoma pre transplantation
- Lyon, Rhone, Franceservice de dermatologie - hopital Edouard Herriot
2021-12-09
Dec 9, 2021N
Not yet recruiting
- Anal Melanoma
- +20 more
- Cabozantinib
- +2 more
- (no location specified)
2022-03-08
Mar 8, 2022M
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +12 more
- Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta and Tyrosinase Related Protein 1
- Jacksonville, Florida
- +1 more
2021-11-03
Nov 3, 2021M
Recruiting
- Metastatic Melanoma
- +6 more
- Ibrutinib
- +2 more
- Rochester, MinnesotaMayo Clinic in Rochester
2022-03-11
Mar 11, 2022C
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +8 more
- Ipilimumab
- +4 more
- Columbus, OhioOhio State University Comprehensive Cancer Center
2021-09-13
Sep 13, 2021F
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-04-04
Apr 4, 2022H
Recruiting
- Melanoma
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2022-01-18
Jan 18, 2022K
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Beta-Glucan
- Louisville, KentuckyUniversity of Louisville
2022-01-07
Jan 7, 2022V
Recruiting
- Melanoma
- Oxford, United KingdomVitaccess Ltd
2021-10-05
Oct 5, 2021D
Active, not recruiting
- Melanoma
- WDVAX
- Boston, Massachusetts
- +1 more
2022-02-22
Feb 22, 2022M
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +2 more
- Binimetinib
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-10
Feb 10, 2022M
Active, not recruiting
- Metastatic Melanoma
- Aldesleukin: All Patients
- +3 more
- Burnsville, MinnesotaUniversity of Minnesota Masonic Cancer Center
2022-02-25
Feb 25, 2022C
Not yet recruiting
- Melanoma
- Community Based Strategies for Early Detection of Melanoma
- (no location specified)
2022-02-08
Feb 8, 2022M
Recruiting
- Melanoma
- +2 more
- 2D or 3D Melanoma Surveillance Photography
- Newcastle, New South Wales, Australia
- +7 more
2022-03-15
Mar 15, 2022C
D
Not yet recruiting
- Malignant Melanoma
- +4 more
- Pembrolizumab
- +2 more
- (no location specified)
2022-03-31
Mar 31, 2022R
Active, not recruiting
- Metastatic Melanoma
- +8 more
- Aldesleukin
- +2 more
- New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
2021-09-20
Sep 20, 2021M
Recruiting
- Melanoma Stage III
- +2 more
- Moscow, Russian Federation
- +1 more
2021-12-23
Dec 23, 2021U
Not yet recruiting
- Melanoma (Skin)
- Melanoma, Uveal
- Oxford, United KingdomOxford University Hospitals NHS Trust
2022-03-29
Mar 29, 2022C
Not yet recruiting
- Advanced Melanoma
- (no location specified)
2022-03-17
Mar 17, 2022H
Recruiting
- Melanoma
- Tampa, FloridaMoffitt Cancer Center
2022-01-19
Jan 19, 2022M
Recruiting
- Melanoma
- Melanoma Stage III
- PET Scan
- +3 more
- New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
2022-04-04
Apr 4, 2022A
Recruiting
- Melanoma
- Pembrolizumab
- Wide Excision and Sentinel Lymph Node (SLN) Biopsy
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2022-01-05
Jan 5, 2022U
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- San Francisco, CaliforniaUniversity of California, San Francisco
2021-12-03
Dec 3, 2021